Leucyl-tRNA synthetase is a tumour suppressor in breast cancer and regulates codon-dependent translation dynamics.
Journal
Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
04
06
2021
accepted:
27
01
2022
pubmed:
16
3
2022
medline:
6
4
2022
entrez:
15
3
2022
Statut:
ppublish
Résumé
Tumourigenesis and cancer progression require enhanced global protein translation
Identifiants
pubmed: 35288656
doi: 10.1038/s41556-022-00856-5
pii: 10.1038/s41556-022-00856-5
pmc: PMC8977047
mid: NIHMS1775937
doi:
Substances chimiques
Codon
0
EMP3 protein, human
0
Membrane Glycoproteins
0
RNA, Transfer
9014-25-9
Amino Acyl-tRNA Synthetases
EC 6.1.1.-
Leucine-tRNA Ligase
EC 6.1.1.4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
307-315Subventions
Organisme : NIGMS NIH HHS
ID : F32 GM133118
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007739
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA261701
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240984
Pays : United States
Organisme : NCI NIH HHS
ID : F30 CA247026
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.
Références
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
pubmed: 21376230
doi: 10.1016/j.cell.2011.02.013
Ruggero, D. Translational control in cancer etiology. Cold Spring Harb. Perspect. Biol. 5, a012336 (2013).
pubmed: 22767671
pmcid: 3552512
doi: 10.1101/cshperspect.a012336
Leprivier, G., Rotblat, B., Khan, D., Jan, E. & Sorensen, P. H. Stress-mediated translational control in cancer cells. Biochim. Biophys. Acta Gene Regul. Mech. 1849, 845–860 (2015).
doi: 10.1016/j.bbagrm.2014.11.002
Loayza-Puch, F. et al. Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature 530, 490–494 (2016).
pubmed: 26878238
doi: 10.1038/nature16982
Ebright, R. Y. et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science 367, 1468–1473 (2020).
pubmed: 32029688
pmcid: 7307008
doi: 10.1126/science.aay0939
Novoa, E. M. & Ribas de Pouplana, L. Speeding with control: codon usage, tRNAs, and ribosomes. Trends Genet. 28, 574–581 (2012).
pubmed: 22921354
doi: 10.1016/j.tig.2012.07.006
Knott, S. R. V. et al. Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554, 378–381 (2018).
pubmed: 29414946
pmcid: 5898613
doi: 10.1038/nature25465
Goodarzi, H. et al. Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell 165, 1416–1427 (2016).
pubmed: 27259150
pmcid: 4915377
doi: 10.1016/j.cell.2016.05.046
Pavon-Eternod, M. et al. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 37, 7268–7280 (2009).
pubmed: 19783824
pmcid: 2790902
doi: 10.1093/nar/gkp787
Kirchner, S. & Ignatova, Z. Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat. Rev. Genet. 16, 98–112 (2014).
pubmed: 25534324
doi: 10.1038/nrg3861
Zhang, Z. et al. Global analysis of tRNA and translation factor expression reveals a dynamic landscape of translational regulation in human cancers. Commun. Biol. 1, 1–11 (2018).
doi: 10.1038/s42003-018-0239-8
Zhou, Z., Sun, B., Nie, A., Yu, D. & Bian, M. Roles of aminoacyl-tRNA synthetases in cancer. Front. Cell Dev. Biol. 8, 1–12 (2020).
doi: 10.3389/fcell.2020.599765
Park, S. G., Schimmel, P. & Kim, S. Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl Acad. Sci. USA 105, 11043–11049 (2008).
pubmed: 18682559
pmcid: 2516211
doi: 10.1073/pnas.0802862105
Vo, M.-N. et al. ANKRD16 prevents neuron loss caused by an editing-defective tRNA synthetase. Nature 557, 510–515 (2018).
pubmed: 29769718
pmcid: 5973781
doi: 10.1038/s41586-018-0137-8
Antonellis, A. et al. Glycyl tRNA synthetase mutations in Charcot–Marie–Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 72, 1293–1299 (2003).
pubmed: 12690580
pmcid: 1180282
doi: 10.1086/375039
Komarov, P. G. et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733 LP–1731737 (1999).
doi: 10.1126/science.285.5434.1733
Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954–961 (1992).
pubmed: 1312220
pmcid: 369527
Testa, G. et al. A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis 38, 151–158 (2004).
pubmed: 15048813
doi: 10.1002/gene.20012
Tavora, B. et al. Tumoural activation of TLR3–SLIT2 axis in endothelium drives metastasis. Nature 586, 299–304 (2020).
pubmed: 32999457
pmcid: 8088828
doi: 10.1038/s41586-020-2774-y
Padmanaban, V. et al. Organotypic culture assays for murine and human primary and metastatic-site tumors. Nat. Protoc. 15, 2413–2442 (2020).
pubmed: 32690957
pmcid: 8202162
doi: 10.1038/s41596-020-0335-3
Han, J. M. et al. Leucyl-tRNA synthetase is an intracellular leucine sensor for the mTORC1-signaling pathway. Cell 149, 410–424 (2012).
pubmed: 22424946
doi: 10.1016/j.cell.2012.02.044
He, X. D. I. et al. Sensing and transmitting intracellular amino acid signals through reversible lysine aminoacylations. Cell Metab. 27, 151–166.e6 (2018).
pubmed: 29198988
doi: 10.1016/j.cmet.2017.10.015
Pavlova, N. N. et al. Translation in amino-acid-poor environments is limited by tRNA Gln charging. eLife https://doi.org/10.7554/eLife.62307 (2020).
Gobet, C. et al. Robust landscapes of ribosome dwell times and aminoacyl-tRNAs in response to nutrient stress in liver. Proc. Natl Acad. Sci. USA https://doi.org/10.1073/pnas.1918145117 (2020).
Evans, M. E., Clark, W. C., Zheng, G. & Pan, T. Determination of tRNA aminoacylation levels by high-throughput sequencing. Nucleic Acids Res. 45, e133 (2017).
pubmed: 28586482
pmcid: 5737633
doi: 10.1093/nar/gkx514
Lund, Elsebet & Dahlberg, J. E. Proofreading and aminoacylation of tRNAs before export from the nucleus. Science 282, 2082–2085 (1998).
pubmed: 9851929
doi: 10.1126/science.282.5396.2082
Elf, J., Nilsson, D., Tenson, T. & Ehrenberg, M. Selective charging of tRNA isoacceptors explains patterns of codon usage. Science 300, 1718–1722 (2003).
pubmed: 12805541
doi: 10.1126/science.1083811
Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).
pubmed: 25307932
pmcid: 4253859
doi: 10.1016/j.cell.2014.09.029
Chan, P. P. & Lowe, T. M. GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic Acids Res. 37, 93–97 (2009).
doi: 10.1093/nar/gkn787
Chan, P. P. & Lowe, T. M. GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes. Nucleic Acids Res. 44, D184–D189 (2016).
pubmed: 26673694
doi: 10.1093/nar/gkv1309
Novoa, E. M., Pavon-Eternod, M., Pan, T. & Ribas De Pouplana, L. A role for tRNA modifications in genome structure and codon usage. Cell 149, 202–213 (2012).
pubmed: 22464330
doi: 10.1016/j.cell.2012.01.050
Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl Acad. Sci. USA 106, 13939–13944 (2009).
pubmed: 19666516
pmcid: 2728999
doi: 10.1073/pnas.0907143106
McGlincy, N. J. & Ingolia, N. T. Transcriptome-wide measurement of translation by ribosome profiling. Methods 126, 112–129 (2017).
pubmed: 28579404
pmcid: 5582988
doi: 10.1016/j.ymeth.2017.05.028
Zecha, J. et al. TMT labeling for the masses: a robust and cost-efficient, in-solution labeling approach. Mol. Cell. Proteom. 18, 1468–1478 (2019).
doi: 10.1074/mcp.TIR119.001385
Wang, Y. W., Cheng, H. L., Ding, Y. R., Chou, L. H. & Chow, N. H. EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer. Biochim. Biophys. Acta Rev. Cancer 1868, 199–211 (2017).
pubmed: 28408326
doi: 10.1016/j.bbcan.2017.04.004
Alaminos, M. et al. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res. 65, 2565–2571 (2005).
pubmed: 15805250
doi: 10.1158/0008-5472.CAN-04-4283
Wang, W. et al. Effector T cells abrogate stroma-mediated chemoresistance in ovarian cancer. Cell 165, 1092–1105 (2016).
pubmed: 27133165
pmcid: 4874853
doi: 10.1016/j.cell.2016.04.009
Xu, Y. et al. Translation control of the immune checkpoint in cancer and its therapeutic targeting. Nat. Med. 25, 301–311 (2019).
pubmed: 30643286
pmcid: 6613562
doi: 10.1038/s41591-018-0321-2
Dittmar, K. A., Sørensen, M. A., Elf, J., Ehrenberg, M. & Pan, T. Selective charging of tRNA isoacceptors induced by amino-acid starvation. EMBO Rep. 6, 151–157 (2005).
pubmed: 15678157
pmcid: 1299251
doi: 10.1038/sj.embor.7400341
Darnell, A. M., Subramaniam, A. R. & O’Shea, E. K. Translational control through differential ribosome pausing during amino acid limitation in mammalian cells. Mol. Cell 71, 229–243.e11 (2018).
pubmed: 30029003
pmcid: 6516488
doi: 10.1016/j.molcel.2018.06.041
Huh, D. et al. A stress‐induced tyrosine‐tRNA depletion response mediates codon‐based translational repression and growth suppression. EMBO J. 40, 1–16 (2021).
doi: 10.15252/embj.2020106696
Shin, S.-H. et al. Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis. Exp. Mol. Med. 40, 229–236 (2008).
pubmed: 18446061
pmcid: 2679304
doi: 10.3858/emm.2008.40.2.229
Gomez, M. A. R. & Ibba, M. Aminoacyl-tRNA synthetases. RNA 26, 910–936 (2020).
doi: 10.1261/rna.071720.119
Perona, J. J. & Hou, Y.-M. Indirect readout of tRNA for aminoacylation. Biochemistry 46, 10419–10432 (2007).
pubmed: 17718520
doi: 10.1021/bi7014647
Tocchini-Valentini, G., Saks, M. E. & Abelson, J. tRNA leucine identity and recognition sets. J. Mol. Biol. 298, 779–793 (2000).
pubmed: 10801348
doi: 10.1006/jmbi.2000.3694
Park, S. J. & Schimmel, P. Evidence for interaction of an aminoacyl transfer RNA synthetase with a region important for the identity of its cognate transfer RNA. J. Biol. Chem. 263, 16527–16530 (1988).
pubmed: 3053691
doi: 10.1016/S0021-9258(18)37421-0
Fender, A., Sissler, M., Florentz, C. & Giegé, R. Functional idiosyncrasies of tRNA isoacceptors in cognate and noncognate aminoacylation systems. Biochimie 86, 21–29 (2004).
pubmed: 14987797
doi: 10.1016/j.biochi.2003.11.011
McFarland, M. R. et al. The molecular aetiology of tRNA synthetase depletion: induction of a GCN4 amino acid starvation response despite homeostatic maintenance of charged tRNA levels. Nucleic Acids Res. 48, 3071–3088 (2020).
pubmed: 32016368
pmcid: 7102972
doi: 10.1093/nar/gkaa055
Guo, M. & Schimmel, P. Essential nontranslational functions of tRNA synthetases. Nat. Chem. Biol. 9, 145–153 (2013).
pubmed: 23416400
pmcid: 3773598
doi: 10.1038/nchembio.1158
Gandin, V. et al. Polysome fractionation and analysis of mammalian translatomes on a genome-wide scale. J. Vis. Exp. https://doi.org/10.3791/51455 (2014).
Xiao, Z., Zou, Q., Liu, Y. & Yang, X. Genome-wide assessment of differential translations with ribosome profiling data. Nat. Commun. 7, 11194 (2016).
pubmed: 27041671
pmcid: 4822032
doi: 10.1038/ncomms11194
Lauria, F. et al. riboWaltz: optimization of ribosome P-site positioning in ribosome profiling data. PLoS Comput. Biol. 14, 1–20 (2018).
doi: 10.1371/journal.pcbi.1006169
Hickernell, F. J. Quadrature error bound. Math. Comput. 67, 299–322 (1998).
doi: 10.1090/S0025-5718-98-00894-1
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
pubmed: 27348712
doi: 10.1038/nmeth.3901
Wagner, K. U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323–4330 (1997).
pubmed: 9336464
pmcid: 147032
doi: 10.1093/nar/25.21.4323